FLAME 30
239 Reports in Biotechnology
Global Markets for Research Antibodies
The global market for research antibodies should reach $3.0 billion by 2022 from $2.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.8%, from 2017 to 2022.
Single-cell Omics: Emerging Technologies and Markets
The global single-cell omics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.
Cancer Stem Cells: Technologies and Global Markets
The global market for cancer stem cells will grow from $745 million in 2017 to $1.9 billion by 2022 with a compound annual growth rate (CAGR) of 21.2% for the period of 2017-2022.
Global Markets for Enzyme Inhibitors
The global market for enzyme inhibitors should reach $179.9 billion by 2022 from $168 billion in 2017 at a compound annual growth rate (CAGR) of 1.4%, from 2017 to 2022.
Botanical and Plant-derived Drugs: Global Markets
The global market for botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022.
Commercial Amino Acids
The U.S. amino acid market was valued at around $1.9 billion in 2016. This market will grow from nearly $2.0 billion in 2017 to $2.5 billion by 2022 with a compound annual growth rate (CAGR) of 4.8% for the period of 2017-2022.
Antibody Drugs: Technologies and Global Markets
The global market for antibody drugs reached $80.8 billion in 2016. The market should reach $114.6 billion by 2022 increasing from $84.5 billion in 2017, at a compound annual growth rate (CAGR) of 6.3% from 2017 through 2022.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Ma...
The global liquid biopsy market should reach $4.5 billion by 2022 from $1.5 billion in 2017 at a compound annual growth rate (CAGR) of 24.2%, from 2017 to 2022.
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Mar...
The global market for microRNA tools reached $756.5 million and $829.8 million in 2015 and 2016, respectively. This market is estimated to reach nearly $1.4 billion in 2021 at a compound annual growth rate (CAGR) of 10.5% for 2016-2021.
Molecular Diagnostics: Technologies and Global Markets
The global molecular diagnostics market was valued at nearly $10.6 billion in 2016. The market is projected to grow at a compound annual growth rate (CAGR) of 14.3% from 2017 through 2022 to reach $12.2 billion by 2017 and $23.8 billion by 2022.
Cell-based Assays: Technologies and Global Markets
The global market for cell-based assays reached $15.2 billion in 2015. This market is expected to increase from $17.1 billion in 2016 to nearly $28.4 billion in 2021 at a compound annual growth rate (CAGR) of 10.6% for 2016-2021.
Induced Pluripotent Stem Cells: Global Markets
The global market for induced pluripotent stem cells (iPSCs) reached $2.1 billion in 2016. The market should reach $3.6 billion in 2021, increasing at a compound annual growth rate (CAGR) of 11.6% from 2016 through 2021.
Next-generation Sequencing: Emerging Clinical Applications and Gl...
The global clinical next-generation sequencing (NGS) market reached $2.7 billion in 2016. This market is expected to grow at a compound annual growth rate (CAGR) of 27%, from nearly $3.2 billion in 2017 to $10.5 billion by 2022.
Global Markets for Media, Sera and Reagents in Biotechnology
The global market for media, sera and reagents used in cell culture will grow from nearly $3.6 billion in 2016 to $4.6 billion by 2021 at a compound annual growth rate (CAGR) of 5.5% between 2016 and 2021.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021.
3D Cell Cultures: Technologies and Global Markets
The three-dimensional cell culture market reached $1.0 billion in 2016 and should reach $3.9 billion in 2021, with a compound annual growth rate (CAGR) of 30.7% from 2016 to 2021.
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics should reach a market size of nearly $9.9 billion by 2024.
Separation Systems for Commercial Biotechnology
The global market for bioseparation reached $18.4 billion in 2015. This market is expected to increase from $19.0 billion in 2016 to nearly $24.0 billion in 2021 at a compound annual growth rate (CAGR) of 4.7% for 2016-2021.
Agricultural Biotechnology: Emerging Technologies and Global Mark...
The global market for agricultural biotechnology reached $29.2 billion in 2016. This market should reach $32.1 billion in 2017 and $53.7 billion in 2022, with a compound annual growth rate (CAGR) of 10.8%.
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics reached nearly $3.2 billion in 2015. This market is expected to increase from $4.3 billion in 2016 to nearly $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 32.3% for 2016-2021.
Global Markets for Protein Labeling
The global protein-labeling market reached $2.2 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 14.1% from 2016 to 2021.
Synthetic Biology: Global Markets
The global synthetic-biology market reached nearly $3.9 billion in 2016 and should reach $11.4 billion by 2021, growing at a compound annual growth rate (CAGR) of 24.0% through 2021.
Global Markets for Enzymes in Industrial Applications
The global market for industrial enzymes reached nearly $4.6 billion and $4.9 billion in 2014 and 2015, respectively. This market is expected to increase from nearly $5.0 billion in 2016 to $6.3 billion in 2021 at a compound annual growth rate (CAGR) of 4.7% for 2016-2021.
Global Markets for Bioengineered Protein Drugs
The global market for bioengineered protein drugs is expected to reach $228.4 billion by 2021 from $172.5 billion in 2016, rising at a compound annual growth rate (CAGR) of 5.8% from 2016 through 2021.
Sample Preparation in Genomics, Proteomics, and Epigenomics: Glob...
The global market for sample preparation in genomics, proteomics and epigenomics reached $5.2 billion in 2015. The market should reach $5.6 billion in 2016 and $7.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.5% from 2016 to 2021.
Choose your License
10 Upcoming Reports in Biotechnology
Global Longevity and Anti-senescence Therapy market
Report Includes
- An overview of the global longevity and anti-senescence therapy market
- Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Detailed description of different therapies such as senolytic drug therapy, gene therapy, and immunotherapy and discussion on how these slow down or reverse aging process
- Coverage of drugs, devices and technologies and information about the various compounds used for the development of anti-ageing therapeutics
- A look at the clinical trials and expected launch of anti-senescence products
- Detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market
Global Microbiome Sequencing Market
Report Includes
- An overview of the global market and technologies for genome sequencing
- Analyses of global market trends, with data from 2017, 2018 and projections of CAGRs through 2023
- Analysis of the present and future opportunities and key factors influencing the in-microbiome sequencing market
- Discussion on impact of genome sequencing on pharmaceutical, biotechnology and healthcare sectors
- Information on automated instruments and discussion on how it facilitates speedy sequencing procedures
- Insights into government initiatives and funding for the development of effective drugs for the treatment and prevention from chronic diseases
- Company profiles of the major players of the market
